UK U-turn on single use for vCJD (variant Creutzfeldt-Jakob disease)-risk surgery
This article was originally published in Clinica
The UK Department of Health is to reintroduce reusable surgical instruments for tonsil and adenoid surgery, thus overturning its decision of almost a year ago to introduce single-use devices to eliminate the risk of patient-to-patient transmission of vCJD in these procedures. The decision has been prompted by the high number of adverse events attributed to the use of single-use instruments in the past year. It is based on the "balance of risks" to patients, says the DoH, on the advice of the British Association of Otorhinolaryngologists.
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.